Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Neurology Minute
00:00
Evaluating Ubrogepant's Impact on Migraine Prodrome Outcomes
This chapter explores a study on Ubrogepant, a migraine treatment, examining its positive effects on patient-reported outcomes during the prodrome phase. The findings reveal significant improvements in functioning, reduced disability, and increased patient satisfaction compared to a placebo.
Transcript
Play full episode
